CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia
Abstract T-cell prolymphocytic leukemia (T-PLL) is a poor prognostic disease with very limited options of efficient therapies. Most patients are refractory to chemotherapies and despite high response rates after alemtuzumab, virtually all patients relapse. Therefore, there is an unmet medical need f...
में बचाया:
मुख्य लेखकों: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
स्वरूप: | पुस्तक |
प्रकाशित: |
BMC,
2020-10-01T00:00:00Z.
|
विषय: | |
ऑनलाइन पहुंच: | Connect to this object online. |
टैग: |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|
इंटरनेट
Connect to this object online.3rd Floor Main Library
बोधानक: |
A1234.567 |
---|---|
प्रति 1 | उपलब्ध |